Other news to note for Nov. 26, 2025

FierceBiotechPredicta links with Spanish university to offer diagnostic for blood cancers

BioPharma DiveSummit pulls $500M share sale a day after announcing it

Endpoints NewsDrugmakers are turning to logistics providers as trade disruptions linger, DHL exec says

BioPharma DiveSensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy

Endpoints NewsSummit withdraws $500M offering, citing 'market conditions'

BioWorldScore in phase I CML trial has Enliven looking ahead to phase III

Clinical OMICsLipid-Protein Biomarker Makes Clinical Debut with Early Ovarian Cancer Detection

Endpoints NewsSensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophy

Endpoints NewsCamurus’ second CRL for acromegaly drug; Teva details workforce cuts

FierceBiotechFierce Biotech heading to UK to host event amid London Life Sciences Week

BioPharma DiveNovartis RNA drug acquired in $12B Avidity deal notches a trial win

Endpoints NewsBiopharma pay report: Top-paid CSOs, CMOs of 2025